ng-nitroarginine methyl ester has been researched along with Atrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, ZM; Li, Y; Liu, K; Liu, WW; Mao, YF; Sun, XJ | 1 |
| Bay, A; Eşrefoğlu, M; Kuruş, M; Oztürk, F | 1 |
| Chen, LW; Hsu, CM; Liu, CH | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Atrophy
| Article | Year |
|---|---|
Helium preconditioning protects against neonatal hypoxia-ischemia via nitric oxide mediated up-regulation of antioxidases in a rat model.
Topics: Animals; Animals, Newborn; Atrophy; Brain; Disease Models, Animal; Enzyme Inhibitors; Helium; Heme Oxygenase (Decyclizing); Hypoxia-Ischemia, Brain; Ischemic Preconditioning; Motor Activity; Neuroprotective Agents; NF-E2-Related Factor 2; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Superoxide Dismutase; Up-Regulation | 2016 |
Protective effect of oral L-arginine supplementation on cyclosporine induced nephropathy in rats.
Topics: Animals; Arginine; Atrophy; Cyclosporine; Dietary Supplements; Female; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley | 2005 |
Nitric oxide synthase inhibitor ameliorates oral total parenteral nutrition-induced barrier dysfunction.
Topics: Administration, Oral; Animals; Atrophy; Bacterial Translocation; Dextrans; Enzyme Activation; Enzyme Inhibitors; Female; Fluorescein-5-isothiocyanate; Ileum; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Isothiuronium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Parenteral Nutrition, Total; Permeability; Rats; Rats, Sprague-Dawley; Solutions | 2000 |